Russell Beyer
Director of Finance/CFO at SAB Sciences, Inc.
Net worth: 1 171 $ as of 2024-04-29
Profile
Russell P.
Beyer is currently the Chief Financial Officer at SAB Sciences, Inc. He previously held the same position at SAB Biotherapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Chief Financial Officer at Big Cypress Acquisition Corp.
Mr. Beyer received an undergraduate degree from St. Lawrence University and an MBA from the University of Rochester Simon Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-13 | 292 ( 0.00% ) | 1 171 $ | 2024-04-29 |
Russell Beyer active positions
| Companies | Position | Start |
|---|---|---|
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Director of Finance/CFO | 2021-08-31 |
Former positions of Russell Beyer
| Companies | Position | End |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 2023-10-26 |
| BIG CYPR | Director of Finance/CFO | - |
Training of Russell Beyer
| University of Rochester Simon Business School | Masters Business Admin |
| St. Lawrence University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Big Cypress Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on November 12, 2020 and is headquartered in Miami Beach, FL. | Finance |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Health Technology |
- Stock Market
- Insiders
- Russell Beyer
